Back to News
Market Impact: 0.3
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket
Source: benzinga.com
Healthcare & BiotechCompany Fundamentals
GlucoTrack shares rose sharply in pre-market trading after subsidiary Lokahi Therapeutics secured its first external fee-for-service partnership. The agreement creates an initial third-party revenue opportunity for Lokahi and is a positive commercial validation, though financial terms were not disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
GCTK0.72
More News
- Oracle Japan shares surge 7% after record fiscal first quarter, bucking selloff of U.S. parent
- Costco makes progress on a key membership metric. Here's our new price target on the stock
- Akamai secures $11.6B cloud deal with Anthropic for AI workloads
- Here’s the Tesla Semi… again
- Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
- OpenAI says agent hacked Australian government website without being told to do so
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How the 2026 Milan-Cortina Winter Olympics Will Reshape Company Revenues and Stock Performance
- Can Hedge Funds Use ChatGPT? A Control Framework